Publications by authors named "F Taran"

The development of innovative strategies enabling chemical reactions in living systems is of great interest for exploring and manipulating biological processes. Herein, we present a pioneering approach based on both bioorthogonal and confined chemistry for intracellular drug synthesis. Exploiting a click-to-release reaction, we engineered nanoparticles capable of synthesizing drugs within cellular environments through bioorthogonal reactions with cyclooctynes.

View Article and Find Full Text PDF

Background: For many years, staging tests have not been routinely employed for low-risk early breast cancer (EBC). However, the role of Ki-67 in determining the need for staging tests in low-risk EBC remains unclear. Our study aimed to assess the number and types of staging diagnostics, additional imaging, false-positive results, and rate of distant metastases in low-risk EBC with low and high Ki-67 (< / ≥ 25%).

View Article and Find Full Text PDF

The accurate quantification of biomarkers is paramount in modern medicine, particularly in cancer where precise diagnosis is imperative for targeted therapy selection. In this paper we described a multiplexed analysis diagnostic approach based on cleavable MS-tagged antibodies. The technology uses MS-tag isotopologues and the sydnonimine-cyclooctyne click-and-release bioorthogonal reaction.

View Article and Find Full Text PDF
Article Synopsis
  • Recurrent gynecological cancers often have a poor prognosis, especially when complications like pelvic local recurrence occur after treatment; therefore, locoregional control is crucial for improving patient outcomes.
  • This study analyzed 40 patients who underwent surgery and intraoperative radiotherapy (IORT) from 2010 to 2022, measuring outcomes such as locoregional control, overall survival, and time without distant metastases.
  • Results indicated that cervical carcinoma was the most common, with 60% of patients having no residual tumor after treatment, while factors like age, disease-free intervals, and IORT techniques were assessed for their impact on survival outcomes.
View Article and Find Full Text PDF

Background: Although adequate physical activity has been shown to be beneficial in early breast cancer, evidence in metastatic breast cancer is sparse and contradictory, which could be related to distinct effects of physical activity on the different molecular cancer subtypes. Therefore, we here evaluated the effect of physical activity on progression-free and overall survival (PFS, OS) in metastatic breast cancer, specifically looking at molecular subtypes.

Methods: International Physical Activity Questionnaire (IPAQ) questionnaires, filled out by patients enrolled in the prospective PRAEGNANT registry (NCT02338167; n = 1,270) were used to calculate metabolic equivalent task (MET) minutes, which were subsequently categorized into low (n = 138), moderate (n = 995) or high IPAQ categories (n = 137).

View Article and Find Full Text PDF